| miR-222 is necessary for exercise-induced cardiac growth and protects against pathological cardiac remodeling X Liu, J Xiao, H Zhu, X Wei, C Platt, F Damilano, C Xiao, V Bezzerides, ... Cell metabolism 21 (4), 584-595, 2015 | 431 | 2015 |
| Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response H Zhu, JW Rhee, P Cheng, S Waliany, A Chang, RM Witteles, H Maecker, ... Current Cardiology Reports 22 (5), 2020 | 252 | 2020 |
| A porous photocurable elastomer for cell encapsulation and culture S Gerecht, SA Townsend, H Pressler, H Zhu, CLE Nijst, JP Bruggeman, ... Biomaterials 28 (32), 4826-4835, 2007 | 141 | 2007 |
| Kruppel-like factor 15 regulates skeletal muscle lipid flux and exercise adaptation SM Haldar, D Jeyaraj, P Anand, H Zhu, Y Lu, DA Prosdocimo, B Eapen, ... Proceedings of the National Academy of Sciences 109 (17), 6739-6744, 2012 | 125 | 2012 |
| Kruppel-like factor 15 is a critical regulator of cardiac lipid metabolism DA Prosdocimo, P Anand, X Liao, H Zhu, S Shelkay, P Artero-Calderon, ... Journal of Biological Chemistry 289 (9), 5914-5924, 2014 | 122 | 2014 |
| Glucocorticoids enhance muscle endurance and ameliorate Duchenne muscular dystrophy through a defined metabolic program A Morrison-Nozik, P Anand, H Zhu, Q Duan, M Sabeh, DA Prosdocimo, ... Proceedings of the National Academy of Sciences 112 (49), E6780-E6789, 2015 | 84 | 2015 |
| Cardiovascular risks in patients with COVID-19: potential mechanisms and areas of uncertainty P Cheng, H Zhu, RM Witteles, JC Wu, T Quertermous, SM Wu, JW Rhee Current cardiology reports 22, 1-6, 2020 | 81 | 2020 |
| Myocarditis surveillance with high-sensitivity troponin I during cancer treatment with immune checkpoint inhibitors S Waliany, JW Neal, S Reddy, H Wakelee, SA Shah, S Srinivas, ... Cardio Oncology 3 (1), 137-139, 2021 | 70 | 2021 |
| Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure. H Waliany, S., Lee, D., Witteles, RM., Neal, JW., Nguyen, PK., Davis, MM ... Annual Review of Pharmacology and Toxicology 61, 2020 | 50* | 2020 |
| Identification of pathogenic immune cell subsets associated with checkpoint inhibitor–induced myocarditis H Zhu, FX Galdos, D Lee, S Waliany, YV Huang, J Ryan, K Dang, ... Circulation 146 (4), 316-335, 2022 | 49 | 2022 |
| Preclinical models of cancer therapy–associated cardiovascular toxicity: a scientific statement from the American Heart Association A Asnani, JJ Moslehi, BB Adhikari, AH Baik, AM Beyer, RA de Boer, ... Circulation research 129 (1), e21-e34, 2021 | 42 | 2021 |
| Pharmacovigilance analysis of cardiac toxicities associated with targeted therapies for metastatic NSCLC S Waliany, H Zhu, H Wakelee, SK Padda, M Das, K Ramchandran, ... Journal of Thoracic Oncology 16 (12), 2029-2039, 2021 | 41 | 2021 |
| Elevated fibroblast growth factor‐2 increases tumor necrosis factor‐α induced endothelial cell death in high glucose AM Clyne, H Zhu, ER Edelman Journal of cellular physiology 217 (1), 86-92, 2008 | 34 | 2008 |
| Low wall shear stress is associated with saphenous vein graft stenosis in patients with coronary artery bypass grafting MO Khan, JS Tran, H Zhu, J Boyd, RRS Packard, RP Karlsberg, AM Kahn, ... Journal of cardiovascular translational research 14, 770-781, 2021 | 28 | 2021 |
| Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis LH Lehmann, MB Heckmann, G Bailly, D Finke, A Procureur, JR Power, ... Circulation 148 (6), 473-486, 2023 | 21 | 2023 |
| Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity? TR Katsumoto, KL Wilson, VK Giri, H Zhu, S Anand, KJ Ramchandran, ... Immunotherapy Advances 2 (1), ltac012, 2022 | 18 | 2022 |
| devCellPy is a machine learning-enabled pipeline for automated annotation of complex multilayered single-cell transcriptomic data FX Galdos, S Xu, WR Goodyer, L Duan, YV Huang, S Lee, H Zhu, C Lee, ... Nature Communications 13 (1), 5271, 2022 | 14 | 2022 |
| Mono-and biallelic protein-truncating variants in alpha-actinin 2 cause cardiomyopathy through distinct mechanisms ME Lindholm, D Jimenez-Morales, H Zhu, K Seo, D Amar, C Zhao, A Raja, ... Circulation: Genomic and Precision Medicine 14 (6), e003419, 2021 | 11 | 2021 |
| Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry J Nowatzke, P Guedeney, N Palaskas, L Lehmann, S Ederhy, H Zhu, ... European Journal of Cancer 177, 197-205, 2022 | 10 | 2022 |
| Immune checkpoint inhibitor cardiotoxicity: Breaking barriers in the cardiovascular immune landscape H Zhu, M Ivanovic, A Nguyen, PK Nguyen, SM Wu Journal of Molecular and Cellular Cardiology 160, 121-127, 2021 | 9 | 2021 |
Sean M WuStanford UniversityVerified email at stanford.edu
